{"id":"https://openalex.org/W4366239114","doi":"https://doi.org/10.1093/jac/dkad114","title":"Animal pharmacokinetics/pharmacodynamics (PK/PD) infection models for clinical development of antibacterial drugs: lessons from selected cases","display_name":"Animal pharmacokinetics/pharmacodynamics (PK/PD) infection models for clinical development of antibacterial drugs: lessons from selected cases","publication_year":2023,"publication_date":"2023-04-18","ids":{"openalex":"https://openalex.org/W4366239114","doi":"https://doi.org/10.1093/jac/dkad114","pmid":"https://pubmed.ncbi.nlm.nih.gov/37071587"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkad114","doi":"https://doi.org/10.1093/jac/dkad114","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkad114","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038646398","display_name":"Jason N. Moore","orcid":"https://orcid.org/0000-0001-7364-3048","observed_orcids":["https://orcid.org/0000-0001-7364-3048"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jason N Moore","raw_affiliation_strings":["Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037295245","display_name":"Lucas Poon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lucas Poon","raw_affiliation_strings":["Department of Medicine, Uniformed Services University of the Health Sciences , 4301 Jones Bridge Rd, Bethesda, MD 20814 , USA","Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Uniformed Services University of the Health Sciences , 4301 Jones Bridge Rd, Bethesda, MD 20814 , USA","institution_ids":["https://openalex.org/I148314036"]},{"raw_affiliation_string":"Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077751051","display_name":"Sonia Pahwa","orcid":"https://orcid.org/0009-0001-2308-3932","observed_orcids":["https://orcid.org/0009-0001-2308-3932"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonia Pahwa","raw_affiliation_strings":["Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039255585","display_name":"Timothy J. Bensman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Bensman","raw_affiliation_strings":["Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010259747","display_name":"Xiaohui Wei","orcid":"https://orcid.org/0000-0001-9105-5186","observed_orcids":["https://orcid.org/0000-0001-9105-5186","https://orcid.org/0000-0001-5086-0103"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaohui (Tracey) Wei","raw_affiliation_strings":["Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019951050","display_name":"Zhixia Yan Danielsen","orcid":"https://orcid.org/0009-0009-0931-6160","observed_orcids":["https://orcid.org/0009-0009-0931-6160"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhixia Yan Danielsen","raw_affiliation_strings":["Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102137625","display_name":"Seong Hoon Jang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seong Jang","raw_affiliation_strings":["Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA","Elevar Therapeutics , 2755 E Cottonwood Pkwy #540, Salt Lake City, UT 84121 , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration , 10903 New Hampshire Ave, Silver Spring, MD 20993 , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"raw_affiliation_string":"Elevar Therapeutics , 2755 E Cottonwood Pkwy #540, Salt Lake City, UT 84121 , USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5038646398"],"corresponding_institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"],"apc_list":{"value":2627,"currency":"GBP","value_usd":3268},"apc_paid":null,"fwci":0.5051,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.45320197,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"78","issue":"6","first_page":"1337","last_page":"1343"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.053700000047683716,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/animal-models-of-infection","display_name":"animal models of infection","score":0.8569999933242798},{"id":"https://openalex.org/keywords/antibacterial-drug-development","display_name":"antibacterial drug development","score":0.8930000066757202},{"id":"https://openalex.org/keywords/pharmacokinetics-pharmacodynamics","display_name":"pharmacokinetics/pharmacodynamics","score":0.9359999895095825},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.8090000152587891},{"id":"https://openalex.org/keywords/translational-research","display_name":"translational research","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.6421951651573181},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5835181474685669},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5667200088500977},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5566158890724182},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5492586493492126},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5138728618621826},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5134135484695435},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.509933590888977},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5043550729751587},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.4423210024833679},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4184056520462036},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2410314977169037},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13032054901123047},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.1264525055885315}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/jac/dkad114","doi":"https://doi.org/10.1093/jac/dkad114","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkad114","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:37071587","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37071587","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Review"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1761247443","https://openalex.org/W1966621081","https://openalex.org/W1993806447","https://openalex.org/W2003786398","https://openalex.org/W2032422158","https://openalex.org/W2102395861","https://openalex.org/W2108525727","https://openalex.org/W2114034330","https://openalex.org/W2122389046","https://openalex.org/W2126918925","https://openalex.org/W2129881065","https://openalex.org/W2134607027","https://openalex.org/W2150760368","https://openalex.org/W2162716119","https://openalex.org/W2262202809","https://openalex.org/W2510161318","https://openalex.org/W2606224033","https://openalex.org/W2769151879","https://openalex.org/W2791395549","https://openalex.org/W2796052358","https://openalex.org/W2901121450","https://openalex.org/W2927629499","https://openalex.org/W2930309673","https://openalex.org/W2955528928","https://openalex.org/W2977133444","https://openalex.org/W2981716604","https://openalex.org/W2989693255","https://openalex.org/W2989732926","https://openalex.org/W3010816592","https://openalex.org/W3027025045","https://openalex.org/W3126879320","https://openalex.org/W3164297925","https://openalex.org/W3166307472"],"related_works":["https://openalex.org/W2060706736","https://openalex.org/W2554560091","https://openalex.org/W2150760368","https://openalex.org/W2756756609","https://openalex.org/W2919778958","https://openalex.org/W2169951238","https://openalex.org/W1982462000","https://openalex.org/W249203084","https://openalex.org/W3022445245","https://openalex.org/W2254530401"],"abstract_inverted_index":{"In":[0],"the":[1,15,64],"wake":[2],"of":[3,19,55,68,88,106],"emerging":[4],"antimicrobial":[5],"resistance,":[6],"antibacterial":[7,20,95,108],"drug":[8,96],"development":[9,18,54,97,105],"has":[10],"become":[11],"more":[12,58],"critical.":[13],"At":[14],"same":[16],"time,":[17],"drugs":[21],"targeting":[22],"specific":[23],"pathogens":[24],"or":[25],"resistance":[26],"phenotypes":[27],"that":[28],"may":[29],"have":[30,50],"low":[31],"prevalence":[32],"presents":[33],"challenges":[34],"because":[35],"it":[36],"is":[37,60],"difficult":[38],"to":[39,62,72,78,93,100],"conduct":[40],"large,":[41],"randomized":[42],"controlled":[43],"trials":[44],"for":[45,103],"such":[46],"drugs.":[47,109],"Animal":[48],"models":[49,71,91],"increasingly":[51],"supported":[52],"clinical":[53],"antibacterials;":[56],"however,":[57],"work":[59],"needed":[61],"optimize":[63],"design":[65],"and":[66,75],"application":[67],"these":[69],"animal":[70,89],"ensure":[73],"clear":[74],"actionable":[76],"translation":[77],"further":[79],"human":[80],"investigation.":[81],"This":[82],"review":[83],"discusses":[84],"recent":[85],"case":[86],"studies":[87],"infection":[90],"used":[92],"support":[94],"in":[98],"order":[99],"illuminate":[101],"considerations":[102],"future":[104],"novel":[107]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-04-20T00:00:00"}